Definitive Contract HHSN268201700002C
Award Date
11/15/16
Potential Completion Date
2/14/20
Potential Value
$2M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Dupage Medical Technology Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Willowbrook, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Sujana Biotech, LLC, a self-certified small disadvantaged business. The contract, valued at $783,488.00, is for the development of an anti-thrombotic monoclonal antibody (MAB) with improved safety and efficacy, under the VITA 2 program. The contract is a definitive, firm fixed-price contract with an ultimate completion date of August 14, 2019. The contract was awarded on November...
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract has a ceiling value of $139,009.50 and an ultimate completion date of December 31, 2017. The prime contractor is Biofortis, LLC, a for-profit limited liability company that provides software solutions and services to support clinical trials and translational research programs. The contract enables the...
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, has been awarded a $886,805 definitive cost-no-fee contract from the National Heart, Lung, and Blood Institute to support the Vascular Interventions/Innovations and Therapeutic Advances program. Under this award, the University will conduct research into selective inhibitors of integrin outside-in signaling as a new generation of anti-thrombotics. The potential value of $886,805.38 reflects the...
This is a $928,761.27 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the University of Illinois to develop a novel drug-based therapy for the treatment of vascular leakage. The contract does not have a set-aside designation. The University of Illinois, as the prime contractor, will conduct the research and development work on this project, which aims to advance new treatments for vascular leakage, a...
The National Heart Lung and Blood Institute, a civilian federal agency, awarded a $11,450.00 firm-fixed-price purchase order to Editco Bio Inc., a self-certified small disadvantaged business, to provide knock-in cell line generation services to support Dr. Martina's cell biology experiments. The contract has an ultimate completion date of December 26, 2024 and was awarded on August 29, 2024. This contract award is not associated with a larger vehicle and does not have a set-aside designation.
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $1,100,000.00 firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, for the manufacture of 200 Active Guidewires for MRI-guided cardiovascular catheterization. This contract is part of the National Heart, Lung, and Blood Institute's Division of Intramural Research's efforts to develop radiation-free heart catheterization...
This is a $293,215.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Technology Holding LLC, a for-profit limited liability company. The contract is for a firm fixed price with a completion date of August 21, 2020. Technology Holding LLC is a small business specializing in research and development across areas like biotechnology, materials science, energy, and defense. Through federal contracts...
This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Pulmokine, Inc. for $1,549,476.97 to conduct IND-enabling studies for a novel inhaled PDGF receptor inhibitor to treat pulmonary arterial hypertension (PAH). The contract has no set-aside designation and was awarded on November 14, 2013, with a completion date of November 14, 2016. Pulmokine, Inc. is the prime contractor, and the contract is for a novel therapy to treat...